Sang Won Seo1, Rebecca F Gottesman2, Jeanne M Clark2, Ruben Hernaez2, Yoosoo Chang2, Changsoo Kim2, Kyoung Hwa Ha2, Eliseo Guallar2, Mariana Lazo2. 1. From the Department of Epidemiology (S.W.S., R.F.G., J.M.C., E.G., M.L.), Welch Center for Prevention, Epidemiology & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Neurology (S.W.S.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Neurology (R.F.G.) and Division of Gastroenterology and Hepatology (J.M.C., R.H., M.L.), The Johns Hopkins University School of Medicine, Baltimore, MD; Department of Occupational and Environmental Medicine (Y.C.), Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine; Department of Preventive Medicine (C.K.), Yonsei University College of Medicine, Seoul; and Cardiovascular and Metabolic Disease Etiology Research Center (K.H.H.), Ajou University School of Medicine, Suwon, Republic of Korea. sangwonseo@empal.com. 2. From the Department of Epidemiology (S.W.S., R.F.G., J.M.C., E.G., M.L.), Welch Center for Prevention, Epidemiology & Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Neurology (S.W.S.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Neurology (R.F.G.) and Division of Gastroenterology and Hepatology (J.M.C., R.H., M.L.), The Johns Hopkins University School of Medicine, Baltimore, MD; Department of Occupational and Environmental Medicine (Y.C.), Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine; Department of Preventive Medicine (C.K.), Yonsei University College of Medicine, Seoul; and Cardiovascular and Metabolic Disease Etiology Research Center (K.H.H.), Ajou University School of Medicine, Suwon, Republic of Korea.
Abstract
OBJECTIVE: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. METHODS: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. RESULTS: Participants with NAFLD showed lower overall performance on the SDLT (β = 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β = 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β = 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β = 0.002, 95% CI 0.0001-0.004). CONCLUSIONS: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.
OBJECTIVE: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. METHODS: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. RESULTS:Participants with NAFLD showed lower overall performance on the SDLT (β = 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β = 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β = 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β = 0.002, 95% CI 0.0001-0.004). CONCLUSIONS: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.
Authors: E F Krieg; D W Chrislip; R E Letz; D A Otto; C J Crespo; W S Brightwell; R L Ehrenberg Journal: Neurotoxicol Teratol Date: 2001 Nov-Dec Impact factor: 3.763
Authors: Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley Journal: Hepatology Date: 2010-09 Impact factor: 17.425
Authors: Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Galit Weinstein; Shira Zelber-Sagi; Sarah R Preis; Alexa S Beiser; Charles DeCarli; Elizabeth K Speliotes; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri Journal: JAMA Neurol Date: 2018-01-01 Impact factor: 18.302
Authors: Nicholette D Palmer; Bratati Kahali; Annapurna Kuppa; Yanhua Chen; Xiaomeng Du; Mary F Feitosa; Lawrence F Bielak; Jeffrey R O'Connell; Solomon K Musani; Xiuqing Guo; Albert V Smith; Kathleen A Ryan; Gudny Eirksdottir; Matthew A Allison; Donald W Bowden; Matthew J Budoff; J Jeffrey Carr; Yii-Der I Chen; Kent D Taylor; Adolfo Correa; Breland F Crudup; Brian Halligan; Jian Yang; Sharon L R Kardia; Lenore J Launer; Yi-Ping Fu; Thomas H Mosley; Jill M Norris; James G Terry; Christopher J O'Donnell; Jerome I Rotter; Lynne E Wagenknecht; Vilmundur Gudnason; Michael A Province; Patricia A Peyser; Elizabeth K Speliotes Journal: Hum Mol Genet Date: 2021-07-09 Impact factor: 6.150
Authors: Tiril P Gurholt; Tobias Kaufmann; Oleksandr Frei; Dag Alnæs; Unn K Haukvik; Dennis van der Meer; Torgeir Moberget; Kevin S O'Connell; Olof D Leinhard; Jennifer Linge; Rozalyn Simon; Olav B Smeland; Ida E Sønderby; Adriano Winterton; Nils Eiel Steen; Lars T Westlye; Ole A Andreassen Journal: Transl Psychiatry Date: 2021-05-18 Impact factor: 6.222